Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation
Open Access
- 1 August 2015
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 21 (8) , 1392-1398
Abstract
No abstract availableKeywords
Funding Information
- University of Texas MD Anderson Cancer Center
- MDACC research fund (110560)
This publication has 33 references indexed in Scilit:
- Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Societe Francophone d'Histocompatibilite et d'Immunogenetique (SFHI) and Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) analysisHaematologica, 2012
- Desensitization in HLA-Incompatible Kidney Recipients and SurvivalNew England Journal of Medicine, 2011
- Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCTBone Marrow Transplantation, 2011
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failureBlood, 2010
- Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipientsBlood, 2006
- Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipientsBlood, 2006
- Effect of HLA Compatibility on Engraftment of Bone Marrow Transplants in Patients with Leukemia or LymphomaNew England Journal of Medicine, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- On the Interpretation of χ 2 from Contingency Tables, and the Calculation of PJournal of the Royal Statistical Society, 1922